AshkanLashkariMD

Oncology • West Hills, CA

Cancer Genetics/Cancer Risk Assessment, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Physician at Wellness Oncology and Hematology

Join to view full profile

Dr. Lashkari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lashkari's full profile

Already have an account?

Office
7320 Woodlake Ave
Suite 330
West Hills, CA 91307
Phone+1 818-346-1773

Education & Training

City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2003 - 2006
David Geffen School of Medicine at UCLAClass of 2003

Certifications & Licensure

CA State Medical License 2005 - 2026
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
Completed
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Completed
Phase 2
Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL Start of enrollment: 2014 Jun 01
Terminated
Phase 2
Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients Start of enrollment: 2014 Mar 08
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

14 citations
Tandem High-dose Chemotherapy Followed by Autologous Transplantation in Patients with Locally Advanced or Metastatic Sarcoma
Ashkan Lashkari, Warren Chow, Frances Valdes, Lucille Leong, V. U. Phan
Anticancer Research. 2009-08-01
37 citations
Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.
George Somlo, Ashkan Lashkari, William T. Bellamy, Todd M. Zimmerman, Joseph Tuscano
British Journal of Haematology. 2011-08-01
31 citations
Effect of Pelvic Lymph Node Irradiation in Salvage Therapy for Patients with Prostate Cancer with a Biochemical Relapse Following Radical Prostatectomy
Brian S. Kim, Ashkan Lashkari, Roy Vongtama, Steve P. Lee, Robert G. Parker
Clinical Prostate Cancer. 2004-09-01

Other Languages

Farsi, French